Cargando…
Downregulation of TPX2 impairs the antitumor activity of CD8+ T cells in hepatocellular carcinoma
Targeting key genes that play dominant roles in T cell dysfunction is an efficient strategy for cancer immunotherapy. Here, we aimed to investigate the role of TPX2 in the antitumor effect of CD8 + T cells in hepatocellular carcinoma (HCC). Flow cytometry was used to assay the level of cell surface...
Autores principales: | Wang, Xiaochen, Wang, Jianchu, Shen, Haiyuan, Luo, Zongjiang, Lu, Xiaojie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913637/ https://www.ncbi.nlm.nih.gov/pubmed/35273149 http://dx.doi.org/10.1038/s41419-022-04645-8 |
Ejemplares similares
-
Genetic and phenotypic difference in CD8(+) T cell exhaustion between chronic hepatitis B infection and hepatocellular carcinoma
por: Wang, Xiaochen, et al.
Publicado: (2019) -
Identification of a Five Immune Term Signature for Prognosis and Therapy Options (Immunotherapy versus Targeted Therapy) for Patients with Hepatocellular Carcinoma
por: Bin, Xiaoyun, et al.
Publicado: (2023) -
Resveratrol exerts antitumor effects by downregulating CD8(+)CD122(+) Tregs in murine hepatocellular carcinoma
por: Zhang, Qunfang, et al.
Publicado: (2020) -
TPX2 enhances the transcription factor activation of PXR and enhances the resistance of hepatocellular carcinoma cells to antitumor drugs
por: Wang, Hongbo, et al.
Publicado: (2023) -
Oxysophocarpine suppresses hepatocellular carcinoma growth and sensitizes the therapeutic blockade of anti‐Lag‐3 via reducing FGL1 expression
por: Wang, Jianchu, et al.
Publicado: (2020)